← FDA DRUG APPROVALS

FDA ANDA · ANDA219477

PREDNISONE DELAYED RELEASE

prednisone

Sponsor: DR REDDYS

APPLICATION
ANDA219477
TYPE
ANDA
ORIGINAL APPROVAL
2025-10-01
LATEST ACTION
2025-10-01
ROUTE
ORAL
DOSAGE FORM
TABLET, DELAYED RELEASE
MARKETING STATUS
Prescription

Products

PREDNISONEPrescription
PREDNISONE 2MG · TABLET, DELAYED RELEASE · ORAL
PREDNISONEPrescription
PREDNISONE 1MG · TABLET, DELAYED RELEASE · ORAL

Approval history

2025-10-01UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →